Neurology International · 2018 · 24 citations · 25 references
Life SciencesNeurologyNeuroscienceDysphagiaNeurodegenerationNeuropathologyGenetic DisordersNeurodegenerative DiseasesNeurodegenerative DisordersAutosomal Recessive InheritanceExternal Globus PallidusGlobus Pallidus External SegmentGlobus Pallidus Internal SegmentPantothenate Kinase-associated NeurodegenerationT2-weighted ImagingTreatment Controversies
2 gene. The clinical presentation may range from only speech disorder to severe generalized dystonia, spasticity, Visual loss, dysphagia and dementia. The hallmark of this disease is eyes of the tiger sign in the medial aspect of bilateral globus pallidus on T2-weighted MRI that is a hyperintense lesion surrounded by hypointensity. Common treatments for PKAN disease include anticholinergics, botulinum toxin, Oral and Intrathecal baclofen, Iron chelation drugs and surgical procedures such as ablative pallidotomy or thalamotomy, Deep brain stimulation. There are many controversies about the pathogenesis and treatment of this disease, and in recent years interesting studies have been done on PKAN disease and other similar diseases. This review summarizes the clinical presentation, etiology, imaging modalities and treatment.
25
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
Nathalie Boddaert, Kim‐Hanh Le Quan Sang, Agnès Rötig et al. · Blood · 2007 · 407 citations
Medicine, Neurology, Neuroscience +15
Neurodegeneration associated with genetic defects in phospholipase A <sub>2</sub>
Allison Gregory, S. K. Westaway, Ida E. Holm et al. · Neurology · 2008 · 266 citations · Full text
Life Sciences, Genetics, Neurology +12